Crystal structure of rivastigmine hydrogen tartrate Form I (Exelon ® ), C 14 H 23 N 2 O 2 (C 4 H 5 O 6 )
Source abstract
Abstract
The crystal structure of rivastigmine hydrogen tartrate has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional techniques. Rivastigmine hydrogen tartrate crystallizes in space group P 2 1 (#4) with a = 17.538 34(5), b = 8.326 89(2), c = 7.261 11(2) Å, β = 98.7999(2)°, V = 1047.929(4) Å 3 , and Z = 2. The un-ionized end of the hydrogen tartrate anions forms a very strong hydrogen bond with the ionized end of another anion to form a chain. The ammonium group of the rivastigmine cation forms a strong discrete hydrogen bond with the carbonyl oxygen atom of the un-ionized end of the tartrate anion. These hydrogen bonds form a corrugated network in the bc -plane. Both hydroxyl groups of the tartrate anion form intramolecular O–H⋯O hydrogen bonds. Several C–H⋯O hydrogen bonds appear to contribute to the crystal energy. The powder pattern is included in the Powder Diffraction File ™ as entry 00-064-1501.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Polymer Synthesis and Characterization · Crystallography and molecular interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. 2014
2. 10.1107/S002188988708709010.1107/S0021889887087090 ↗
3. 10.1021/ar00172a00510.1021/ar00172a005 ↗
4. 10.1002/anie.19951555110.1002/anie.199515551 ↗
5. 10.1063/1.46788210.1063/1.467882 ↗
6. Wavefunction, Inc. (2013). Spartan ‘14 Version 1.1.0, Wavefunction Inc., 18401 Von Karman Ave., Suite 370, Irvine CA 92612.
7. 10.1039/B818330A10.1039/B818330A ↗
8. Larson · 2004
9. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
10. ICDD (2014). PDF-4+ 2014 (Database), edited by Dr. Soorya Kabekkodu , International Centre for Diffraction Data, Newtown Square, PA, USA.
11. 10.1107/S002188980604211710.1107/S0021889806042117 ↗
12. 2013
13. Chen W. M. , Wen F. H. , Jin F. , and Mi J. (2009). “Synthesis and crystal structure of (S)-rivastigmine D-(+)-DTTA,” Huaxue Shiji (Chin.) (Chemical Reagents) 7, 010; CSD Refcode MAKKEQ.
14. Overeem A. and Vinent H. T. (2008). “Polymorphs of rivastigmine hydrogentartrate,” US Patent Application 2008/0255231.
15. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
16. 10.1107/S002188989400421810.1107/S0021889894004218 ↗
17. 10.1107/S002188980904291510.1107/S0021889809042915 ↗
18. Bravais · 1866
19. 10.1007/BF0054909610.1007/BF00549096 ↗
20. Wolff · 2012
21. A new law of crystal morphology extending the law of Bravais
22. Benkic P. , Smrkolj M. , Pecavar A. , Stropnik T. , Vrbinc M. , Vrecer F. , and Pelko M. (2008). “Amorphous and crystalline forms of rivastigmine hydrogen tartrate,” European Patent Application 1942100.
23. 10.1107/S010876810402030010.1107/S0108768104020300 ↗
24. 10.1021/ci049780b10.1021/ci049780b ↗
25. 10.1107/S010876810200389010.1107/S0108768102003890 ↗
26. Etudes sur la loi de Bravais
27. 10.1063/1.296926010.1063/1.2969260 ↗
28. 10.1107/S002188980706790810.1107/S0021889807067908 ↗
29. 10.1107/S010876819901508610.1107/S0108768199015086 ↗
30. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
31. Open Babel: an open chemical toolbox
32. 10.1107/S090904950801843810.1107/S0909049508018438 ↗
33. CRYSTAL: a computational tool for the ab initio study of the electronic properties of crystals
34. 10.1107/S002188980100224210.1107/S0021889801002242 ↗